Clinical Scorecard: Scaling Diabetic Eye Care in Vietnam
At a Glance
| Category | Detail |
|---|---|
| Condition | Diabetic Retinopathy |
| Key Mechanisms | Screening, referral, and treatment services enhancement; AI-assisted screening; comprehensive patient-centered care. |
| Target Population | Individuals with diabetes in Vietnam, approximately 27,000 people with diabetic eye disease. |
| Care Setting | Partner hospitals in Hanoi and Ho Chi Minh City. |
Key Highlights
- Partnership between Orbis and Roche Pharma to address diabetic retinopathy.
- Aim to scale up screening and treatment services for diabetic eye disease.
- Introduction of AI-assisted screening through Cybersight telemedicine platform.
- Focus on generating real-world data for national guidelines.
- Comprehensive model designed for continuity of care.
Guideline-Based Recommendations
Diagnosis
- Implement advanced diagnostic tools in partner hospitals.
- Utilize AI-assisted screening for early detection.
Management
- Develop national technical guidelines for diabetic retinopathy management.
Monitoring & Follow-up
- Track patient outcomes and generate real-world data.
Risks
- Diabetic retinopathy is a leading cause of avoidable blindness.
Patient & Prescribing Data
Individuals with diabetes, particularly those at risk for diabetic retinopathy.
Focus on timely intervention and continuity of care from diagnosis to treatment.
Clinical Best Practices
- Enhance training for healthcare professionals on diabetic eye care.
- Ensure access to screening and treatment services in urban hospitals.
- Promote patient-centered care models to improve outcomes.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
